North China Pharmaceutical Company Ltd. (600812.SS)
CNY 5.49
(-0.54%)
CNY 5.49
(-0.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.12 Billion | 10.49 Billion | 10.38 Billion | 11.49 Billion | 10.88 Billion | 9.21 Billion |
| Cost of Revenue | 6.9 Billion | 6.99 Billion | 6.7 Billion | 7.3 Billion | 6.28 Billion | 5.32 Billion |
| Gross Profit | 3.21 Billion | 3.5 Billion | 3.68 Billion | 4.18 Billion | 4.59 Billion | 3.88 Billion |
| Operating Expenses | 3.05 Billion | 2.72 Billion | 3 Billion | 3.39 Billion | 3.84 Billion | 3.2 Billion |
| Selling, General and Administrative Expenses | 1.63 Billion | 2.08 Billion | 2.45 Billion | 2.93 Billion | 3.37 Billion | 2.81 Billion |
| Research and Development Expenses | 297.2 Million | 217.3 Million | 153.08 Million | 136.15 Million | 67 Million | 71.88 Million |
| Other Expenses | 481.22 Million | 422.79 Million | 395.84 Million | 331.17 Million | 404.87 Million | -6.47 Million |
| Cost and Expenses | 9.96 Billion | 9.72 Billion | 9.7 Billion | 10.7 Billion | 10.13 Billion | 8.53 Billion |
| Operating Income | 540.51 Million | 872.74 Million | 779.66 Million | 810.15 Million | 803.96 Million | 204.85 Million |
| Interest Expense | 511.9 Million | 599.39 Million | 642.69 Million | 572.02 Million | 532.89 Million | 424.12 Million |
| Income Tax Expense | 109.14 Million | 113.7 Million | 99.52 Million | 82.2 Million | 89 Million | 52.56 Million |
| Earnings before Tax | 116.8 Million | -565.07 Million | 134.9 Million | 186.68 Million | 236.9 Million | 198.38 Million |
| Net Income | 4.89 Million | -678.78 Million | 35.38 Million | 97.32 Million | 153.44 Million | 150.64 Million |
| Earnings Per Share Basic | 0.00 | -0.40 | 0.02 | 0.06 | 0.11 | 0.09 |
| Earnings Per Share Diluted | 0.00 | -0.40 | 0.02 | 0.06 | 0.11 | 0.09 |
| Weighted Average Shares Outstanding | 1.63 Billion | 1.71 Billion | 1.7 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.63 Billion | 1.71 Billion | 1.7 Billion | 1.63 Billion | 1.63 Billion | 1.63 Billion |
| Gross Margin | 0.32 | 0.33 | 0.35 | 0.36 | 0.42 | 0.42 |
| EBIT Margin | 0.15 | 0.16 | 0.14 | 0.12 | 0.13 | 0.14 |
| Profit Margin | 0.00 | -0.06 | 0.00 | 0.01 | 0.01 | 0.02 |
| EBITDA | 1.51 Billion | 796.95 Million | 1.48 Billion | 1.37 Billion | 1.37 Billion | 1.16 Billion |
| Earnings Before Tax Margin | 0.05 | 0.08 | 0.08 | 0.07 | 0.07 | 0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.32 Billion | 2.64 Billion | 2.53 Billion | 2.12 Billion | 10.01 Billion | 2.74 Billion |
| Cost of Revenue | 1.6 Billion | 1.93 Billion | 1.77 Billion | 1.47 Billion | 7.02 Billion | 1.92 Billion |
| Gross Profit | 724.03 Million | 711.51 Million | 757.36 Million | 641.69 Million | 2.98 Billion | 815.56 Million |
| Operating Expenses | 564.08 Million | 541.12 Million | 599.94 Million | 513.74 Million | 2.44 Billion | 647.65 Million |
| Selling, General and Administrative Expenses | 757 Million | 502.02 Million | 520.19 Million | 456.76 Million | - | 748.48 Million |
| Research and Development Expenses | 91.12 Million | 53.15 Million | 76.22 Million | 65.08 Million | - | 63.43 Million |
| Other Expenses | -284.03 Million | 14.05 Million | -3.52 Million | 8.1 Million | 2.23 Million | 1.31 Million |
| Cost and Expenses | 2.16 Billion | 2.47 Billion | 2.37 Billion | 1.99 Billion | 9.47 Billion | 2.57 Billion |
| Operating Income | 75.5 Million | 170.39 Million | 157.42 Million | 127.95 Million | 540.51 Million | 38.47 Million |
| Interest Expense | 107.21 Million | 118.15 Million | 120.54 Million | 122.18 Million | 501.89 Million | 118.72 Million |
| Income Tax Expense | 24.02 Million | 27.28 Million | 25.23 Million | 32.44 Million | 109.14 Million | 32.2 Million |
| Earnings before Tax | 72.96 Million | 77.91 Million | 50.51 Million | 19.05 Million | 116.8 Million | 39.78 Million |
| Net Income | 30.47 Million | 53.83 Million | 18.15 Million | -23.08 Million | 4.89 Million | 1.42 Million |
| Earnings Per Share Basic | 0.02 | 0.03 | 0.01 | -0.01 | - | 0.00 |
| Earnings Per Share Diluted | 0.02 | 0.03 | 0.01 | -0.01 | - | 0.00 |
| Weighted Average Shares Outstanding | 1.71 Billion | 1.71 Billion | 1.71 Billion | 1.71 Billion | 1.71 Billion | 1.71 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.71 Billion | 1.71 Billion | 1.71 Billion | 1.71 Billion | 1.71 Billion | 1.71 Billion |
| Gross Margin | 0.31 | 0.27 | 0.30 | 0.30 | 0.30 | 0.30 |
| EBIT Margin | 0.08 | 0.14 | 0.08 | 0.18 | - | 0.07 |
| Profit Margin | 0.01 | 0.02 | 0.01 | -0.01 | 0.00 | 0.00 |
| EBITDA | 180.18 Million | 383.18 Million | 201.09 Million | 377.48 Million | - | 183.66 Million |
| Earnings Before Tax Margin | 0.03 | 0.06 | 0.06 | 0.06 | 0.05 | 0.01 |
AACTF
PII
GSMGW
TXG
5264
STRINV